Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure

Hiroyuki Nakayama1, Xiongwen Chen, Christopher P Baines

  • 1Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, USA.

Insights

Heart failure can result from myocyte necrosis due to calcium overload, not just apoptosis. Blocking calcium channels or beta-adrenergic receptors prevents this necrosis, revealing a new pathway in heart disease.

Area of Science:

  • Cardiovascular Biology
  • Cell Death Mechanisms
  • Molecular Cardiology

Background:

  • Heart failure is traditionally linked to cardiac myocyte apoptosis.
  • The role of myocyte necrosis in heart failure pathogenesis is less understood.

Purpose of the Study:

  • To investigate the role of myocyte necrosis in heart failure.
  • To explore the mechanisms linking calcium overload, beta-adrenergic signaling, and myocyte death.

Main Methods:

  • Utilized inducible transgenic mice with enhanced L-type Ca2+ channel (LTCC) activity.
  • Administered beta-adrenergic receptor agonists and antagonists.
  • Investigated the role of cyclophilin D and Bcl-2 in myocyte death.

Main Results:

  • Enhanced LTCC activity induced myocyte necrosis, pump dysfunction, and premature death.
  • Beta-adrenergic stimulation exacerbated necrosis and heart failure.
  • LTCC blockers and beta-adrenergic antagonists prevented necrosis and heart failure.
  • Loss of cyclophilin D prevented calcium-induced necrosis and heart failure.
  • Bcl-2 overexpression did not prevent necrosis-driven heart failure.

Conclusions:

  • Myocyte necrosis, driven by calcium overload and linked to beta-adrenergic signaling, is a significant contributor to heart failure.
  • Mitochondrial permeability transition pore and cyclophilin D are critical in this necrotic pathway.
  • Heart failure is a complex disorder involving both apoptotic and necrotic cell loss.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...